NOTICE TO THE MEDIA - Government of Canada to make an announcement aimed at preventing and addressing elder abuse
SHERBROOKE, QC, June 14, 2023 /CNW/ - Élisabeth Brière, Parliamentary Secretary of the Honourable Carolyn Bennett, Minister of Mental and Addictions and Associate Minister of Health, will announce funding aimed at preventing and addressing elder abuse in Quebec.
There will be a media availability immediately following the announcement.
Media may attend the announcement either in person or via Zoom.
Date June 15, 2023
Time 9:00 AM (EDT)
Location
The event will be held in-person at:
Espace Anne-Hébert, Faculté des lettres et sciences humaines, Université de Sherbrooke, room A3-330 2500, Université Boulevard Sherbrooke (Quebec) J1K 2R1
Johnson & Johnson will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12th, at the Loews Miami Beach Hotel, Miami Beach, Florida. Jennifer Taubert, Executive Vice President, Worldwide Chairman,...
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that it has set a record date of May 17, 2024 (the "Record Date") for the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary, Inhibrx...
DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and cardio-renal disease, today provided a business update and financial results for the quarter ended March...
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced new data from a study further confirming the performance of its DecisionDx-UM test as a robust independent predictor of...
Catalent, Inc. ("Catalent"), the leader in enabling the development and supply of better treatments for patients worldwide, today announced financial results for the third quarter of fiscal 2024, which ended March 31, 2024.
"I am pleased to report...
MediPharm Labs Corp. ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its first quarter financial results for the period ended March 31,...
